🇺🇸 peptisorb in United States

14 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 2 reports (14.29%)
  2. Erythema — 2 reports (14.29%)
  3. General Physical Health Deterioration — 2 reports (14.29%)
  4. Infective Pulmonary Exacerbation Of Cystic Fibrosis — 2 reports (14.29%)
  5. Abdominal Wall Disorder — 1 report (7.14%)
  6. Arrhythmia — 1 report (7.14%)
  7. Articular Calcification — 1 report (7.14%)
  8. Axonal And Demyelinating Polyneuropathy — 1 report (7.14%)
  9. Benign Prostatic Hyperplasia — 1 report (7.14%)
  10. Blood Bilirubin Increased — 1 report (7.14%)

Source database →

Other Other approved in United States

Frequently asked questions

Is peptisorb approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for peptisorb in United States?

Jagiellonian University is the originator. The local marketing authorisation holder may differ — check the official source linked above.